In this manner, the study of Bao et al. (2006) showed that CD133+ enriched stem cell-like glioma cells (SCLGC) produced tumors with an increased tumor vascularity, necrosis, and hemorrhage. The gene discussed is PROM1; the disease is neoplasm.